Sequence mutations of the substrate binding pocket of stem cell factor and multidrug resistance protein ABCG2 in renal cell cancer: A possible link to treatment resistance

By            

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1697-1700

Spandidos Publications

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 142-151

Bentham Science Publishers

Access to resources Recommend Favorite

IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses

By Falkensammer Claudia   Jöhrer Karin   Gander Hubert   Ramoner Reinhold   Putz Thomas   Rahm Andrea   Greil Richard   Bartsch Georg   Thurnher Martin  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1228-1237

Springer Publishing Company

Access to resources Recommend Favorite

High dose recombinant tumour necrosis factor (rTNF ) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer

By Lejeune F.J.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1009-1016

Elsevier

Access to resources Recommend Favorite

Surgical Treatment of Renal Cell Cancer Liver Metastases: A Population-Based Study

By Ruys Anthony  

Annals of Surgical Oncology, Vol. 18, Iss. 7, 2011-07 ,pp. : 1932-1938

Springer Publishing Company

Access to resources Recommend Favorite